Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance

AJ Narayan, LA Downey, B Manning… - … & Biobehavioral Reviews, 2022 - Elsevier
Cannabidiol's (CBD) safety profile and broad action has made it a popular treatment option
for anxiety and co-occurring sleep disturbance. However, its efficacy in healthy and clinical …

[HTML][HTML] The pharmacological treatment of chronic pain: from guidelines to daily clinical practice

G Marcianò, C Vocca, M Evangelista, C Palleria… - Pharmaceutics, 2023 - mdpi.com
In agreement with the International Association for the Study of Pain, chronic pain is an
unpleasant sensory and emotional experience associated with actual or potential tissue …

Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline

JW Busse, P Vankrunkelsven, L Zeng, AF Heen… - bmj, 2021 - bmj.com
Clinical question What is the role of medical cannabis or cannabinoids for people living with
chronic pain due to cancer or non-cancer causes? Current practice Chronic pain is common …

Assessment of orally administered Δ9-tetrahydrocannabinol when coadministered with cannabidiol on Δ9-tetrahydrocannabinol pharmacokinetics and …

CA Zamarripa, TR Spindle, R Surujunarain… - JAMA Network …, 2023 - jamanetwork.com
Importance Controlled clinical laboratory studies have shown that cannabidiol (CBD) can
sometimes attenuate or exacerbate the effects ofΔ9-tetrahydrocannabinol (Δ9-THC). No …

Clinical practice guidelines for cannabis and cannabinoid-based medicines in the management of chronic pain and co-occurring conditions

AD Bell, C MacCallum, S Margolese… - Cannabis and …, 2024 - liebertpub.com
Background: One in five individuals live with chronic pain globally, which often co-occurs
with sleep problems, anxiety, depression, and substance use disorders. Although these …

Medicinal cannabis prescribing in Australia: an analysis of trends over the first five years

SL MacPhail, MA Bedoya-Pérez, R Cohen… - Frontiers in …, 2022 - frontiersin.org
A regulatory framework allowing legal access to medicinal cannabis (MC) products has
operated in Australia since November 2016. MC prescribing by healthcare practitioners …

[PDF][PDF] Beyond the pain: a systematic narrative review of the latest advancements in fibromyalgia treatment

PR Ram, M Jeyaraman, N Jeyaraman… - Cureus, 2023 - cureus.com
Fibromyalgia is a complex chronic pain disorder that significantly impacts the quality of life of
affected individuals. The etiology of fibromyalgia remains elusive, necessitating effective …

Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions

JD Henson, L Vitetta, S Hall - Inflammopharmacology, 2022 - Springer
Abstract Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-
only medicines are prospective treatments for chronic pain, stress, anxiety, depression, and …

The basic science of cannabinoids

A Sideris, J Lauzadis, M Kaczocha - Anesthesia & Analgesia, 2024 - journals.lww.com
The cannabis plant has been used for centuries to manage the symptoms of various
ailments including pain. Hundreds of chemical compounds have been identified and …

Cannabidiol (CBD) in rheumatic diseases (musculoskeletal pain)

KF Boehnke, W Häuser, MA Fitzcharles - Current Rheumatology Reports, 2022 - Springer
Abstract Purpose of Review This review will address the many uncertainties surrounding the
medical use of cannabidiol (CBD). We will begin with an overview of the legal and …